REPORT HIGHLIGHT
Extracellular Matrix Patches Market size was valued at USD 28.9 Million in 2022, expanding at a CAGR of 8.1% from 2023 to 2030.
Extracellular matrix (ECM) patches are biomaterials engineered to mimic the natural structure and function of the body's ECM, the supportive network present between cells in tissues and organs. These patches are designed using a combination of natural and/or synthetic materials that resemble the ECM's composition, including proteins, sugars, and other molecules. ECM patches serve as scaffolds to support tissue repair, regeneration, and wound healing by providing a framework for cells to adhere, proliferate, and differentiate. They can be utilized in various medical applications, such as repairing damaged tissues, promoting healing after injuries or surgeries, and aiding in the regeneration of organs. These patches hold immense promise in the field of regenerative medicine due to their ability to mimic the natural ECM environment, facilitating cellular interactions and tissue regeneration processes.
Extracellular Matrix Patches Market- Market Dynamics
Increased occurrence of congenital heart disease (CHD) and traumatic injuries that often necessitate repair and reconstruction procedures to propel market demand
The market is experiencing significant growth driven by an increased occurrence of congenital heart disease (CHD) and traumatic injuries that often necessitate repair and reconstruction procedures. According to the Centers for Disease Control and Prevention's 2022 report, 18.2 million individuals had coronary artery disease, with 70% of them undergoing surgery. Additionally, around 40,000 neonates are born with CHD annually in the U.S. The growing use of extracellular matrix (ECM) in hernia and pelvic reconstruction surgeries is fostering product growth. Abdominal wall hernia surgery is among the most common globally, with over 1 million procedures conducted annually in the U.S. Several companies are concentrating on developing extracellular matrix for pelvic reconstruction and hernia repair. Aroa Biosurgery, a soft tissue regeneration firm, introduced Myriad Morcells in a morcellized format named Myriad Matrix, receiving U.S. FDA clearance in April 2021.
Extracellular Matrix Patches Market- Key Insights
- As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2023-2030)
- Based on Raw Material segmentation, porcine was predicted to show maximum market share in the year 2022
- Based on end user segmentation, soft tissue repair was the leading type in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Extracellular Matrix Patches Market- Segmentation Analysis:
The Global Extracellular Matrix Patches Market is segmented on the basis of Raw Material, Application, End User, and Region.
The market is divided into three categories based on Raw Material: porcine, bovine, and others. Porcine held a significant share in 2022 due to their extensive utilization in repair and reconstructive surgeries. These grafts, akin to human collagen, reduce the risk of allergic reactions. Their advantages include durability, pliability, and minimal scar formation, driving their demand. Additionally, their widespread availability and high adoption rates further bolster segmental growth.
The market is divided into six categories based on Application: soft tissue repair, cardiac repair, dural repair, pericardial repair, wound healing, and vascular repair & reconstruction. Soft tissue repair holds the largest share of revenue in 2022 mainly due to the increasing number of hernia repair surgeries-especially inguinal hernia-growing trauma surgery rates, and heightened treatment levels. Globally, inguinal hernia repair constitutes one of the most frequently performed surgical procedures, with over 20 million patients annually. Furthermore, greater recognition and uptake of extracellular matrix among healthcare providers in developed nations are expected to boost this segment.
Extracellular Matrix Patches Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Extracellular Matrix Patches Market- Competitive Landscape:
Market players in this sector are adopting several strategic approaches to strengthen their position. These strategies encompass mergers, acquisitions, and partnerships to expand their market reach and enhance product distribution. Additionally, companies are focusing on extensive research and development initiatives to innovate and introduce advanced extracellular matrix (ECM) products tailored for specific applications. They aim to capitalize on the growing demand for ECM patches by investing in marketing efforts to increase awareness among healthcare providers. Furthermore, some organizations are conducting comprehensive studies and clinical trials to validate the effectiveness of ECM in diverse surgical grafts, aiming to secure regulatory approvals and gain a competitive edge in the market. Market players are employing strategies like mergers, acquisitions, partnerships, and agreements to expand their regional presence and effectively market and distribute their products.
Recent Developments:
In September 2021, Terumo Corporation announced the global surgical graft study PANTHER, examining various knitted and woven surgical grafts and cardiovascular patches in both retrospective and prospective capacities.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET KEY PLAYERS
- Cook Group
- Coloplast Group
- Smith & Nephew
- Koninklijke DSM N.V.
- MTF Biologics
- Boston Scientific Corporation
- Medtronic
- Baxter
- Aziyo Biologics
- Admedus
- Others
GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY RAW MATERIAL
GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY APPLICATION
- Cardiac Repair
- Vascular Repair & Reconstruction
- Pericardial Repair
- Dural Repair
- Soft Tissue Repair
- Wound Healing
GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY END USER
- Hospitals
- Home care settings
GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA